{{Rsnum
|rsid=9567552
|Gene=BRCA2
|Chromosome=13
|position=32316090
|Orientation=plus
|GMAF=0.2227
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=BRCA2
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 51.6 | 42.2 | 6.2
| HCB | 60.0 | 33.3 | 6.7
| JPT | 28.9 | 57.8 | 13.3
| YRI | 69.8 | 28.6 | 1.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 60.0 | 33.3 | 6.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20872766
|Title=Association analysis of [[PALB2]] and BRCA2 in [[bipolar disorder]] and [[schizophrenia]] in a [[Scandinavian]] case-control sample
}}

{{PMID|17428325|OA=1
}} Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.

{{PMID|19500380|OA=1
}} LD2SNPing: linkage disequilibrium plotter and RFLP enzyme mining for tag SNPs.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}